GB2544782B - Solution - Google Patents

Solution Download PDF

Info

Publication number
GB2544782B
GB2544782B GB1520902.6A GB201520902A GB2544782B GB 2544782 B GB2544782 B GB 2544782B GB 201520902 A GB201520902 A GB 201520902A GB 2544782 B GB2544782 B GB 2544782B
Authority
GB
United Kingdom
Prior art keywords
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
GB1520902.6A
Other versions
GB201520902D0 (en
GB2544782A (en
Inventor
Van De Lockand Pierre
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fontus Health Ltd
Original Assignee
Fontus Health Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fontus Health Ltd filed Critical Fontus Health Ltd
Priority to GB1520902.6A priority Critical patent/GB2544782B/en
Publication of GB201520902D0 publication Critical patent/GB201520902D0/en
Priority to PCT/EP2016/078910 priority patent/WO2017089595A1/en
Publication of GB2544782A publication Critical patent/GB2544782A/en
Application granted granted Critical
Publication of GB2544782B publication Critical patent/GB2544782B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
GB1520902.6A 2015-11-26 2015-11-26 Solution Active GB2544782B (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB1520902.6A GB2544782B (en) 2015-11-26 2015-11-26 Solution
PCT/EP2016/078910 WO2017089595A1 (en) 2015-11-26 2016-11-25 Solution comprising glycerophosphoric acid and magnesium salt thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1520902.6A GB2544782B (en) 2015-11-26 2015-11-26 Solution

Publications (3)

Publication Number Publication Date
GB201520902D0 GB201520902D0 (en) 2016-01-13
GB2544782A GB2544782A (en) 2017-05-31
GB2544782B true GB2544782B (en) 2020-07-15

Family

ID=55177297

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1520902.6A Active GB2544782B (en) 2015-11-26 2015-11-26 Solution

Country Status (2)

Country Link
GB (1) GB2544782B (en)
WO (1) WO2017089595A1 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010131994A1 (en) * 2009-05-15 2010-11-18 Obshchestvo S Ogranichennoj Otvetstvennost'yu "Wds" Medicine for dental diseases prophylaxis
US20110117033A1 (en) * 2008-07-07 2011-05-19 Obthestvo S Ogranichennoyj Otvetstvennostjyu <Wds> Therapeutic and prophylactic formulation for oral care

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2502735B2 (en) * 1975-01-23 1978-11-23 J. Pfrimmer & Co, 8520 Erlangen Use of glycerophosphates
JPH06312923A (en) * 1993-04-30 1994-11-08 Green Cross Corp:The Nutrient infusion solution for peripheral venous nutrition
KR20050085218A (en) * 2002-12-10 2005-08-29 마사야 다나카 Skin material for external use and antiprutiric agent for external use and wrinkle-reducing instrument using the same
JP5684454B2 (en) * 2005-11-25 2015-03-11 “ダブリューディーエス” カンパニー Oral care therapeutic and prophylactic compositions

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110117033A1 (en) * 2008-07-07 2011-05-19 Obthestvo S Ogranichennoyj Otvetstvennostjyu <Wds> Therapeutic and prophylactic formulation for oral care
WO2010131994A1 (en) * 2009-05-15 2010-11-18 Obshchestvo S Ogranichennoj Otvetstvennost'yu "Wds" Medicine for dental diseases prophylaxis

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
European Journal of Neurology Vol. 7, 2000, P Rossier et al., "The effect of magnesium oral therapy on spasticity in a patient with multiple sclerosis", pages 741-744 *

Also Published As

Publication number Publication date
GB201520902D0 (en) 2016-01-13
GB2544782A (en) 2017-05-31
WO2017089595A1 (en) 2017-06-01

Similar Documents

Publication Publication Date Title
DK3389557T3 (en) Transseptalt leveringssystem
DK3320033T3 (en) Polyethylenterephthalat-depolymerisering
DK3256579T3 (en) Cysteinprotease
DK3256580T3 (en) Cysteinprotease
DK3298030T3 (en) Anti-cancerfusionspolypeptid
DK3250592T3 (en) Anti-transthyretin-antistoffer
DK3373882T3 (en) Patientisolator
DK3284069T3 (en) Pos-terminal
DK3390996T3 (en) Trykbart tids-temperaturindikatorsystem
DK3380145T3 (en) Injektionsapparat
DK3336185T3 (en) Antistof
DK3272750T3 (en) Morphinan-derivat
DK3324768T3 (en) Tørdragt
AU361999S (en) Ballustrade
DK3133099T3 (en) Polymermodificeret polyoldispersion
DK3282866T3 (en) Proteinfibre
DK3250312T3 (en) Urea-metalnitrat-scr-system
DK3294653T3 (en) Justerbar inline-port
DK3242882T3 (en) Cgrp-antagonistpeptider
GB2544782B (en) Solution
AU5516P (en) LEP08 Lepidosperma squamatum
AU5511P (en) PTK647 Epichloe coenophiala
AU366552S (en) Nutblock
GB201522111D0 (en) Balaclavas
AU367131S (en) USB-charger